The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement - Athyros, V G; Alexandrides, T K; Bilianou, H (Metabolism, 2017)
et al.